SI1147103T1 - Phenantrhridine-n-oxides with pde-iv inhibiting activity - Google Patents

Phenantrhridine-n-oxides with pde-iv inhibiting activity

Info

Publication number
SI1147103T1
SI1147103T1 SI200030713T SI200030713T SI1147103T1 SI 1147103 T1 SI1147103 T1 SI 1147103T1 SI 200030713 T SI200030713 T SI 200030713T SI 200030713 T SI200030713 T SI 200030713T SI 1147103 T1 SI1147103 T1 SI 1147103T1
Authority
SI
Slovenia
Prior art keywords
oxides
phenantrhridine
pde
inhibiting activity
compounds
Prior art date
Application number
SI200030713T
Other languages
English (en)
Slovenian (sl)
Inventor
Dieter Flockerzi
Hermann Amschler
Armin Hatzelmann
Daniela Bundschuh
Rolf Beume
Hildegard Boss
Hans-Peter Kley
Beate Schmidt
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1147103T1 publication Critical patent/SI1147103T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Junction Field-Effect Transistors (AREA)
SI200030713T 1999-01-15 2000-01-13 Phenantrhridine-n-oxides with pde-iv inhibiting activity SI1147103T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100693 1999-01-15
EP00901539A EP1147103B1 (en) 1999-01-15 2000-01-13 Phenantrhridine-n-oxides with pde-iv inhibiting activity
PCT/EP2000/000192 WO2000042034A1 (en) 1999-01-15 2000-01-13 Phenanthridine-n-oxides with pde-iv inhibiting activity

Publications (1)

Publication Number Publication Date
SI1147103T1 true SI1147103T1 (en) 2005-10-31

Family

ID=8237350

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030713T SI1147103T1 (en) 1999-01-15 2000-01-13 Phenantrhridine-n-oxides with pde-iv inhibiting activity

Country Status (12)

Country Link
US (1) US6534519B1 (enExample)
EP (1) EP1147103B1 (enExample)
JP (1) JP2003502278A (enExample)
AT (1) ATE294793T1 (enExample)
AU (1) AU2290000A (enExample)
CA (1) CA2359449A1 (enExample)
DE (1) DE60019894T2 (enExample)
DK (1) DK1147103T3 (enExample)
ES (1) ES2241571T3 (enExample)
PT (1) PT1147103E (enExample)
SI (1) SI1147103T1 (enExample)
WO (1) WO2000042034A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0007527B1 (pt) * 1999-01-15 2011-12-27 fenilfenantridinas com atividade inibitària de pde-iv, seu uso, bem como medicamento compreendendo as mesmas.
AU782908B2 (en) 2000-01-11 2005-09-08 Altana Pharma Ag Phenanthridine-N-oxides
AU2001283935B2 (en) 2000-07-14 2006-07-13 Altana Pharma Ag Novel 6-heteroarylphenanthridines
WO2004019944A1 (en) * 2002-08-29 2004-03-11 Altana Pharma Ag 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2281658T3 (es) 2002-08-29 2007-10-01 Nycomed Gmbh 3-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
JP2007500685A (ja) * 2003-07-31 2007-01-18 アルタナ　ファルマ　アクチエンゲゼルシャフト 新規の６−フェニルフェナントリジン
CA2533636A1 (en) * 2003-07-31 2005-02-10 Altana Pharma Ag Novel 6-phenylphenanthridines
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2005023253A1 (en) * 2003-09-05 2005-03-17 Altana Pharma Ag Use of pde4 inhibitors for the treatment of diabetes mellitus
EP1720835B1 (en) 2004-02-18 2012-12-12 Nycomed GmbH Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors
HRP20130828T1 (en) 2004-03-03 2013-09-30 Takeda Gmbh Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
EP1725534A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
NZ560268A (en) 2005-03-02 2010-12-24 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
CN102600144A (zh) 2005-03-08 2012-07-25 奈科明有限责任公司 治疗糖尿病的罗氟司特
JP5362729B2 (ja) 2007-10-04 2013-12-11 エフ．ホフマン−ラ ロシュ アーゲー シクロプロピルアリールアミド誘導体及びその使用
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines
US5475003A (en) * 1994-03-03 1995-12-12 Syntex (U.S.A.) Inc. 8-phenylcyclopentenoquinoline and 8-phenylcyclohexenoquinoline derivatives
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
EA001205B1 (ru) * 1996-01-31 2000-12-25 Бык Гульден Ломберг Хемише Фабрик Гмбх Новые фенантридины
WO1997035854A1 (de) * 1996-03-26 1997-10-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue in 6-position substituierte phenanthridine
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
GB9622386D0 (en) 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
ATE234300T1 (de) 1996-11-11 2003-03-15 Altana Pharma Ag Benzonaphthyridine als bronchialtherapeutika
GB9626643D0 (en) 1996-12-21 1997-02-12 Astra Pharma Prod Compounds
WO1998040382A1 (en) * 1997-03-07 1998-09-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel tetrazoles
DK0988302T3 (da) 1997-06-03 2003-06-02 Altana Pharma Ag Benzonaphthyridiner
CA2297923A1 (en) 1997-07-25 1999-02-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors
US6436952B1 (en) 1998-08-31 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-N-oxides comprising a PDE3 and PDE4 inhibiting activity

Also Published As

Publication number Publication date
EP1147103B1 (en) 2005-05-04
US6534519B1 (en) 2003-03-18
WO2000042034A1 (en) 2000-07-20
DK1147103T3 (da) 2005-08-29
DE60019894T2 (de) 2006-01-12
CA2359449A1 (en) 2000-07-20
AU2290000A (en) 2000-08-01
EP1147103A1 (en) 2001-10-24
ATE294793T1 (de) 2005-05-15
ES2241571T3 (es) 2005-11-01
PT1147103E (pt) 2005-08-31
JP2003502278A (ja) 2003-01-21
DE60019894D1 (de) 2005-06-09

Similar Documents

Publication Publication Date Title
BG105561A (en) Phenylphenanthridines with pde-iv inhibiting activity
SI1147103T1 (en) Phenantrhridine-n-oxides with pde-iv inhibiting activity
CY2473B1 (en) New phenanthridines.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
AU2904300A (en) Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
PL338339A1 (en) Novel derivatives of tetrazole
SI1147088T1 (sl) 6-arilfenantridini s PDE-IV inhibirajoco aktivnostjo
SI1147087T1 (en) Phenanthridine-n-oxides with pde-iv inhibiting activity
DE59909760D1 (de) Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
PL341239A1 (en) Dihydrobenzofuranes